Your browser is no longer supported. Please, upgrade your browser.
Settings
MDXG MiMedx Group, Inc. daily Stock Chart
MDXG [NASD]
MiMedx Group, Inc.
Index- P/E4.99 EPS (ttm)0.31 Insider Own7.50% Shs Outstand111.04M Perf Week-47.37%
Market Cap172.38M Forward P/E3.45 EPS next Y0.45 Insider Trans0.00% Shs Float98.20M Perf Month-47.37%
Income- PEG0.33 EPS next Q0.11 Inst Own70.08% Short Float62.40% Perf Quarter-70.54%
Sales303.47M P/S0.57 EPS this Y45.50% Inst Trans- Short Ratio11.82 Perf Half Y-73.86%
Book/sh1.35 P/B1.15 EPS next Y40.60% ROA- Target Price18.50 Perf Year-86.79%
Cash/sh- P/C- EPS next 5Y15.00% ROE- 52W Range0.95 - 18.25 Perf YTD-87.69%
Dividend- P/FCF- EPS past 5Y31.85% ROI- 52W High-91.49% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low63.42% ATR0.54
Employees690 Current Ratio- Sales Q/Q31.30% Oper. Margin- RSI (14)32.71 Volatility31.51% 21.26%
OptionableYes Debt/Eq- EPS Q/Q425.70% Profit Margin- Rel Volume0.47 Prev Close1.54
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.19M Price1.55
Recom2.50 SMA20-40.18% SMA50-64.12% SMA200-72.43% Volume2,454,986 Change0.81%
Feb-26-18Downgrade Lake Street Buy → Hold
Feb-20-18Downgrade Needham Strong Buy → Hold
Feb-20-18Downgrade Needham Buy → Hold
Sep-06-17Reiterated Needham Strong Buy $20 → $21
Sep-05-17Reiterated Needham Strong Buy $20 → $21
Jul-28-17Reiterated Lake Street Buy $16 → $18
May-23-17Downgrade First Analysis Sec Equal-Weight → Underweight
Mar-03-17Initiated Piper Jaffray Overweight $10
Dec-12-16Initiated UBS Sell $9
Nov-08-16Initiated Aegis Capital Buy
Apr-27-16Downgrade First Analysis Sec Overweight → Equal-Weight $14 → $9
Apr-12-16Reiterated Needham Strong Buy $13 → $12
Apr-11-16Reiterated Needham Strong Buy $13 → $12
Jan-20-16Reiterated First Analysis Sec Overweight $11 → $15
Dec-18-15Reiterated Canaccord Genuity Buy $10 → $12
Nov-16-15Upgrade Needham Buy → Strong Buy $13
Oct-30-15Upgrade Northland Capital Market Perform → Outperform $10 → $10
Oct-14-15Reiterated Needham Buy $15 → $13
Jul-29-15Downgrade Needham Strong Buy → Buy $15
Jul-17-15Initiated Brean Capital Buy $16
Dec-12-18 07:00AM  Today's Research Reports on Trending Tickers: MiMedx Group and Tandem Diabetes Care ACCESSWIRE
Dec-11-18 07:25PM  [$$] MiMedx Called on Two Lawmakers for Help Before Its Accounting Scandal The Wall Street Journal +21.26%
04:47PM  [$$] MiMedx Called on Two Lawmakers for Help Before Its Accounting Scandal The Wall Street Journal
Dec-06-18 08:12AM  [$$] MiMedx to Shed Jobs as Part of Overhaul The Wall Street Journal -59.32%
Dec-05-18 07:27PM  [$$] MiMedx to Shed Jobs as Part of Overhaul The Wall Street Journal
10:12AM  [$$] Help Wanted, Get in on Ground Floor The Wall Street Journal
08:05AM  MiMedx Announces Resignation Of Outside Auditor PR Newswire
08:02AM  MiMedx Announces Leadership Changes And Promotions PR Newswire
08:00AM  MiMedx Announces Organizational Realignment Program PR Newswire
Nov-20-18 09:05AM  4 Healthcare Stocks You Should Get To Know Before 2019 ACCESSWIRE -10.13%
Nov-08-18 07:05AM  Today's Research Reports on Trending Tickers: Tandem Diabetes Care and MiMedx ACCESSWIRE -19.40%
Nov-07-18 05:57PM  Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600 PR Newswire -41.16%
02:16PM  [$$] Nasdaq to Delist MiMedx Amid Financial Probe The Wall Street Journal
01:08PM  Here's Why MiMedx Group Shares Are Imploding 30% Today Motley Fool
12:24PM  MDXG News: MiMedx Stock Plunges on Nasdaq Delisting Notice InvestorPlace
09:55AM  MiMedx stock plunges after receiving delisting notice from Nasdaq MarketWatch
08:02AM  MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq PR Newswire
08:00AM  MiMedx Receives Nasdaq Delisting Notification PR Newswire
Nov-06-18 12:29PM  MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference PR Newswire
Oct-31-18 01:26PM  MiMedx to Present Clinical and Scientific Studies at SAWC Fall Meeting PR Newswire
Oct-10-18 07:28AM  MiMedx founder and former CEO Pete Petit prepares for battle American City Business Journals -6.62%
Oct-07-18 08:13PM  [$$] MiMedx Kept Cheaper Products Out of Its Offerings to VA Hospitals The Wall Street Journal
Oct-05-18 05:30AM  [$$] MiMedx Kept Cheaper Products Out of Its Offerings to VA Hospitals The Wall Street Journal -12.40%
Oct-04-18 08:48PM  Here's Why MiMedx Group, Inc. Gained 16.6% in September Motley Fool
Sep-25-18 01:11PM  How to Identify a Perfect Short Target GuruFocus.com
08:30AM  MiMedx Publishes Positive Results From Clinical Study Of Human Umbilical Cord For Diabetic Foot Ulcers PR Newswire
Sep-21-18 03:36PM  MiMedx Stock Shoots Higher After Earlier Drop InvestorPlace
08:00AM  Today's Research Reports on Trending Tickers: MiMedx Group and Galectin Therapeutics ACCESSWIRE
07:26AM  MiMedx says ex-CEO Parker Petit, other execs engaged in 'conduct detrimental to the business' American City Business Journals
Sep-20-18 10:00PM  Kaskela Law LLC Announces Investigation of MiMedx Group, Inc. on Behalf of Current Stockholders - MDXG ACCESSWIRE +12.73%
08:30PM  [$$] Former MiMedx Executives to Lose Compensation The Wall Street Journal
05:51PM  MiMedx Ex-CEO Criticizes Unfair Probe That Led to His Ouster Bloomberg
05:15PM  MiMedx Announces Nasdaq Listing Extension PR Newswire
05:10PM  Mimedx Provides Update on Previously Announced Senior Executive Separations PR Newswire
Sep-10-18 12:44PM  Here's Why MiMedx Group Inc. Rose 24.7% in August Motley Fool
Aug-24-18 08:30AM  MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix® PR Newswire +5.95%
Aug-16-18 04:33PM  Why Dillard's, MiMedx Group, and Global Net Lease Slumped Today Motley Fool -11.31%
Aug-15-18 10:47PM  [$$] Health Insurer Shuns Amniotic-Tissue Product From MiMedx The Wall Street Journal
07:34PM  [$$] Health Insurer Shuns 'Unproven' Amniotic-Tissue Products The Wall Street Journal
05:15PM  MiMedx Receives Additional Nasdaq Listing Notice Due to Late Form 10-Q PR Newswire
01:30PM  MiMedx Provides Additional Information and Context to Wall Street Journal Article PR Newswire
Aug-14-18 08:42PM  [$$] Insurer Stops Reimbursing for Some MiMedx Products The Wall Street Journal -11.11%
07:11PM  [$$] Insurer Stops Reimbursing for Some MiMedx Products The Wall Street Journal
05:00PM  Yet Another Setback Caused MiMedx Group Shares to Tumble Today Motley Fool
Aug-13-18 08:00AM  MiMedx announces Nasdaq listing extension and Hearing Date PR Newswire +6.99%
Aug-09-18 10:00AM  MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia PR Newswire
Aug-02-18 08:30AM  MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International PR Newswire +5.24%
Aug-01-18 11:00AM  Schubert Jonckheer & Kolbe LLP Launches Investigation into Possible Breaches of Fiduciary Duty by MiMedx Group, Inc.'s Directors and Officers PR Newswire -5.65%
Jul-27-18 03:00PM  Here's Why MiMedx Group Inc. Stock Is Falling Today Motley Fool -13.54%
Jul-26-18 07:20PM  [$$] MiMedx Gets Delisting Notice From Nasdaq The Wall Street Journal +10.85%
05:00PM  MiMedx Announces Receipt of Nasdaq Letter PR Newswire
Jul-23-18 12:18PM  [$$] Highflying Medical Firm, a Help to Wounded Veterans, Falls to Earth The Wall Street Journal
Jul-20-18 08:05AM  Todays Research Reports on Stocks to Watch: MiMedx Group and BiopharmX ACCESSWIRE -6.97%
Jul-18-18 04:30PM  MiMedx Appoints Mark Graves Chief Compliance Officer To Strengthen Corporate Compliance Practices PR Newswire
07:10AM  Free Technical Research on Medtronic and Three More Medical Equipment Equities ACCESSWIRE
Jul-13-18 07:39AM  These 17 stocks may be tasty for bottom-feeding investors MarketWatch
Jul-10-18 06:11AM  Hynes Keller & Hernandez, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) PR Newswire
Jul-05-18 09:47AM  2 Biotech Stocks at New Lows. Can They Recover? Motley Fool -5.53%
Jul-03-18 03:00PM  Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Board of Directors of MiMedx Group, Inc. (MDXG) on Behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
08:00AM  Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and MiMedx ACCESSWIRE
07:51AM  Benzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium Benzinga
06:52AM  The bad news keeps coming for MiMedx and its new auditor EY MarketWatch
Jul-02-18 04:42PM  Why MiMedx Group, Core Laboratories, and Nordstrom Slumped Today Motley Fool -38.50%
04:26PM  Anadarko and MiMedx fall; Perry Ellis and Dell jump Associated Press
01:04PM  MiMedx Shares Plummet as CEO and COO Resign Amid Investigation TheStreet.com
12:01PM  Pete Petit out as MiMedx CEO, company's COO also resigns American City Business Journals
11:49AM  EQUITY ALERT: Rosen Law Firm Continues to Investigate Breaches of Fiduciary Duties By Management of MiMedx Group, Inc. Business Wire
11:02AM  Why MiMedx Group Inc. Stock Is Being Obliterated Today Motley Fool
08:00AM  MiMedx Announces Leadership Changes And Corporate Actions PR Newswire
Jun-19-18 01:33PM  Should You Be Holding MiMedx Group Inc (NASDAQ:MDXG)? Simply Wall St.
Jun-18-18 07:20AM  Free Pre-Market Technical Recap on MiMedx Group and Three Additional Medical Equipment Stocks ACCESSWIRE
Jun-11-18 11:56AM  Federal Probes at MiMedx Carry a Familiar Ring for CEO Bloomberg
Jun-08-18 02:59PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of MiMedx Group, Inc. (MDXG) PR Newswire
01:19PM  NEW INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MiMedx Group, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:45AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties By Management of MiMedx Group, Inc. MDXG Business Wire
Jun-07-18 02:38PM  MiMedx to Restate Years of Financial Statements The Wall Street Journal -23.39%
12:55PM  Kaskela Law LLC Announces Investigation of MiMedx Group, Inc. on Behalf of Stockholders - MDXG ACCESSWIRE
12:03PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Behalf of MiMedx Group, Inc. Investors Business Wire
10:55AM  MiMedx to restate financial statements, replaces CFO Reuters
10:30AM  KASKELA LAW LLC: Investigation of MiMedx Group, Inc. on Behalf of Stockholders Business Wire
09:58AM  MiMedx Audit Results In Restatement Of 5 Years Of Financials Benzinga
09:57AM  Atlanta biomedical company MiMedx ousts two execs, restating financials following investigation American City Business Journals
09:28AM  MiMedx's stock plunges to pace premarket losers after restatement plans, CFO departure MarketWatch
07:20AM  MiMedx to restate financial statements, appoints interim CFO Reuters
07:15AM  MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress PR Newswire
07:00AM  MiMedx to restate certain historical financial statements PR Newswire
Jun-04-18 03:47PM  Hedge Fund Sues MiMedx Over Short-Selling Claims Bloomberg
May-24-18 08:46AM  MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session Zacks
May-23-18 04:44PM  Why MiMedx Group Shares Rallied as Much as 24% Today Motley Fool +11.17%
May-18-18 04:30PM  MiMedx Receives NASDAQ Notice of Late Form 10-Q Filing PR Newswire
May-10-18 09:00AM  MiMedx To Participate In The Bank of America Merrill Lynch Healthcare Conference On May 16, 2018 PR Newswire
08:00AM  MiMedx Comments On Matters Related To Former VA Employees PR Newswire
May-09-18 04:32PM  Why MiMedx Group Inc. Stock Fell Today Motley Fool -7.49%
02:33PM  U.S. indicts three veterans healthcare providers over MiMedx payments Reuters
12:48PM  Health-Care Workers Accused by U.S. of Taking Bribes From MiMedx Bloomberg
Apr-27-18 02:40AM  Edited Transcript of MDXG earnings conference call or presentation 26-Apr-18 2:30pm GMT Thomson Reuters StreetEvents
Apr-26-18 08:30AM  MiMedx Reports Unreviewed First Quarter Revenue Exceeded Upper End Of Its Guidance PR Newswire
Apr-25-18 10:47AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action Against MiMedx Group, Inc. (MDXG) & Lead Plaintiff Deadline: April 25, 2018 ACCESSWIRE +10.90%
10:10AM  MDXG DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving MiMedx Group Inc. and a Lead Plaintiff Deadline of April 25, 2018 ACCESSWIRE
Apr-24-18 10:50PM  MIMEDX 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against MiMedx Group Inc. - MDXG Business Wire
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Taylor William CharlesPresident and COOFeb 27Option Exercise1.6520,00033,000557,057Feb 28 05:47 PM